Argininosuccinate synthetase 1 (ASS1) staining and reporting followed the previous protocol.5,20 Immune phenotyping was performed for CD3 (Cat#A0452, Dako/Agilent, Santa Clara, CA, USA) and PD-L1 (Cat#13684S, Cell Signaling, Danvers, MA, USA), staining were conducted as described previously.21

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.